| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | TAP complex binding | 1.06e-05 | 9 | 102 | 3 | GO:0062061 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 1.06e-05 | 9 | 102 | 3 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP1 binding | 1.51e-05 | 10 | 102 | 3 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 1.51e-05 | 10 | 102 | 3 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 1.51e-05 | 10 | 102 | 3 | GO:0046977 | |
| GeneOntologyMolecularFunction | MHC class I protein binding | 2.07e-05 | 32 | 102 | 4 | GO:0042288 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 2.75e-05 | 12 | 102 | 3 | GO:0030881 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 8.35e-05 | 17 | 102 | 3 | GO:0046703 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 1.38e-04 | 20 | 102 | 3 | GO:0042608 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.20e-04 | 58 | 102 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | ceramide 1-phosphate binding | 5.34e-04 | 7 | 102 | 2 | GO:1902387 | |
| GeneOntologyMolecularFunction | ceramide 1-phosphate transfer activity | 5.34e-04 | 7 | 102 | 2 | GO:1902388 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 5.44e-04 | 130 | 102 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | ceramide transfer activity | 7.09e-04 | 8 | 102 | 2 | GO:0120017 | |
| GeneOntologyMolecularFunction | sphingolipid transfer activity | 9.09e-04 | 9 | 102 | 2 | GO:0120016 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 1.29e-03 | 42 | 102 | 3 | GO:0071889 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 1.65e-03 | 12 | 102 | 2 | GO:0002162 | |
| GeneOntologyMolecularFunction | U1 snRNP binding | 1.65e-03 | 12 | 102 | 2 | GO:1990446 | |
| GeneOntologyMolecularFunction | miRNA binding | 1.89e-03 | 48 | 102 | 3 | GO:0035198 | |
| GeneOntologyMolecularFunction | peptide antigen binding | 2.01e-03 | 49 | 102 | 3 | GO:0042605 | |
| GeneOntologyMolecularFunction | snRNP binding | 2.96e-03 | 16 | 102 | 2 | GO:0070990 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 3.10e-03 | 57 | 102 | 3 | GO:0120013 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 6.08e-06 | 8 | 100 | 3 | GO:0002485 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class I | 4.59e-05 | 41 | 100 | 4 | GO:0002474 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 5.91e-05 | 16 | 100 | 3 | GO:0002486 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway | 7.16e-05 | 17 | 100 | 3 | GO:0002484 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 7.16e-05 | 17 | 100 | 3 | GO:0002476 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of peptide antigen via MHC class Ib | 8.56e-05 | 18 | 100 | 3 | GO:0002428 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 8.56e-05 | 18 | 100 | 3 | GO:0042590 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 1.39e-04 | 4 | 100 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I | 1.82e-04 | 23 | 100 | 3 | GO:0019885 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen | 2.35e-04 | 25 | 100 | 3 | GO:0002483 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation via MHC class Ib | 2.35e-04 | 25 | 100 | 3 | GO:0002475 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 5.15e-07 | 14 | 102 | 4 | GO:0042824 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 3.89e-06 | 7 | 102 | 3 | GO:0032398 | |
| GeneOntologyCellularComponent | MHC class I protein complex | 1.32e-05 | 10 | 102 | 3 | GO:0042612 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 5.19e-05 | 42 | 102 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 7.30e-05 | 17 | 102 | 3 | GO:0033106 | |
| GeneOntologyCellularComponent | lumenal side of membrane | 8.82e-05 | 48 | 102 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.86e-04 | 23 | 102 | 3 | GO:0005797 | |
| GeneOntologyCellularComponent | nuclear chromosome | 2.49e-04 | 254 | 102 | 7 | GO:0000228 | |
| GeneOntologyCellularComponent | MHC protein complex | 2.70e-04 | 26 | 102 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 2.71e-04 | 64 | 102 | 4 | GO:0012507 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | EPPK1 IQGAP2 TUBG2 CAMSAP3 AKNA TUBG1 SPTBN4 DNAH17 COBL CEP295 PLEC DMD PSRC1 | 4.28e-04 | 899 | 102 | 13 | GO:0099513 |
| GeneOntologyCellularComponent | spindle pole | 5.10e-04 | 205 | 102 | 6 | GO:0000922 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 6.59e-04 | 35 | 102 | 3 | GO:0098553 | |
| GeneOntologyCellularComponent | spindle microtubule | 8.35e-04 | 86 | 102 | 4 | GO:0005876 | |
| GeneOntologyCellularComponent | condensed nuclear chromosome | 1.03e-03 | 91 | 102 | 4 | GO:0000794 | |
| GeneOntologyCellularComponent | perineuronal net | 1.03e-03 | 10 | 102 | 2 | GO:0072534 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.26e-03 | 11 | 102 | 2 | GO:0098966 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.26e-03 | 11 | 102 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.47e-03 | 443 | 102 | 8 | GO:0098791 | |
| GeneOntologyCellularComponent | centriole | 1.56e-03 | 172 | 102 | 5 | GO:0005814 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.78e-03 | 13 | 102 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | mitotic spindle microtubule | 2.06e-03 | 14 | 102 | 2 | GO:1990498 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 2.08e-03 | 110 | 102 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | spindle | 2.16e-03 | 471 | 102 | 8 | GO:0005819 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.22e-03 | 112 | 102 | 4 | GO:0055038 | |
| GeneOntologyCellularComponent | microvillus | 3.11e-03 | 123 | 102 | 4 | GO:0005902 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 3.15e-03 | 293 | 102 | 6 | GO:0030658 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 3.30e-03 | 125 | 102 | 4 | GO:0140534 | |
| GeneOntologyCellularComponent | lateral element | 3.82e-03 | 19 | 102 | 2 | GO:0000800 | |
| GeneOntologyCellularComponent | transport vesicle | 3.91e-03 | 519 | 102 | 8 | GO:0030133 | |
| GeneOntologyCellularComponent | centrosome | ILRUN TUBG2 CAMSAP3 AKNA BIRC6 TUBG1 BNIP2 ALMS1 PLEKHG6 CEP295 | 4.37e-03 | 770 | 102 | 10 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule | 4.58e-03 | 533 | 102 | 8 | GO:0005874 | |
| GeneOntologyCellularComponent | gamma-tubulin complex | 4.66e-03 | 21 | 102 | 2 | GO:0000930 | |
| GeneOntologyCellularComponent | recycling endosome | 4.67e-03 | 222 | 102 | 5 | GO:0055037 | |
| GeneOntologyCellularComponent | supramolecular fiber | EPPK1 IQGAP2 TUBG2 CAMSAP3 AKNA TUBG1 SPTBN4 DNAH17 COBL CEP295 PLEC DMD PSRC1 | 4.80e-03 | 1179 | 102 | 13 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | EPPK1 IQGAP2 TUBG2 CAMSAP3 AKNA TUBG1 SPTBN4 DNAH17 COBL CEP295 PLEC DMD PSRC1 | 5.08e-03 | 1187 | 102 | 13 | GO:0099081 |
| GeneOntologyCellularComponent | costamere | 5.11e-03 | 22 | 102 | 2 | GO:0043034 | |
| MousePheno | spinal cord inflammation | 1.03e-05 | 8 | 81 | 3 | MP:0030987 | |
| MousePheno | dysmetria | 3.32e-05 | 2 | 81 | 2 | MP:0003314 | |
| Domain | CH | 1.90e-06 | 70 | 99 | 6 | PF00307 | |
| Domain | CH | 2.43e-06 | 73 | 99 | 6 | PS50021 | |
| Domain | CH-domain | 2.85e-06 | 75 | 99 | 6 | IPR001715 | |
| Domain | MHC_I_a_C | 2.86e-06 | 6 | 99 | 3 | IPR010579 | |
| Domain | MHC_I_C | 2.86e-06 | 6 | 99 | 3 | PF06623 | |
| Domain | Spectrin_repeat | 1.59e-05 | 29 | 99 | 4 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 2.38e-05 | 32 | 99 | 4 | IPR018159 | |
| Domain | SPEC | 2.38e-05 | 32 | 99 | 4 | SM00150 | |
| Domain | CH | 2.43e-05 | 65 | 99 | 5 | SM00033 | |
| Domain | Gamma_tubulin | 2.78e-05 | 2 | 99 | 2 | IPR002454 | |
| Domain | - | 3.73e-05 | 71 | 99 | 5 | 1.10.418.10 | |
| Domain | ALMS_motif | 8.32e-05 | 3 | 99 | 2 | IPR029299 | |
| Domain | ALMS_motif | 8.32e-05 | 3 | 99 | 2 | PF15309 | |
| Domain | PH | 1.16e-04 | 278 | 99 | 8 | SM00233 | |
| Domain | PH_DOMAIN | 1.19e-04 | 279 | 99 | 8 | PS50003 | |
| Domain | PH_domain | 1.22e-04 | 280 | 99 | 8 | IPR001849 | |
| Domain | Glycolipid_transfer_prot_dom | 1.66e-04 | 4 | 99 | 2 | IPR014830 | |
| Domain | BNIP2 | 1.66e-04 | 4 | 99 | 2 | PF12496 | |
| Domain | GLTP | 1.66e-04 | 4 | 99 | 2 | PF08718 | |
| Domain | Bcl2-/adenovirus-E1B | 1.66e-04 | 4 | 99 | 2 | IPR022181 | |
| Domain | CRAL_TRIO | 1.79e-04 | 21 | 99 | 3 | PF00650 | |
| Domain | MHC_I | 1.79e-04 | 21 | 99 | 3 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.79e-04 | 21 | 99 | 3 | IPR001039 | |
| Domain | Actinin_actin-bd_CS | 2.37e-04 | 23 | 99 | 3 | IPR001589 | |
| Domain | - | 2.37e-04 | 23 | 99 | 3 | 3.40.525.10 | |
| Domain | Spectrin | 2.37e-04 | 23 | 99 | 3 | PF00435 | |
| Domain | ACTININ_2 | 2.37e-04 | 23 | 99 | 3 | PS00020 | |
| Domain | ACTININ_1 | 2.37e-04 | 23 | 99 | 3 | PS00019 | |
| Domain | SEC14 | 3.05e-04 | 25 | 99 | 3 | SM00516 | |
| Domain | CRAL_TRIO | 3.85e-04 | 27 | 99 | 3 | PS50191 | |
| Domain | - | 4.11e-04 | 6 | 99 | 2 | 3.90.1290.10 | |
| Domain | CRAL-TRIO_dom | 4.30e-04 | 28 | 99 | 3 | IPR001251 | |
| Domain | RhoGEF | 4.66e-04 | 68 | 99 | 4 | SM00325 | |
| Domain | RhoGEF | 5.21e-04 | 70 | 99 | 4 | PF00621 | |
| Domain | DH_2 | 5.21e-04 | 70 | 99 | 4 | PS50010 | |
| Domain | DH-domain | 5.50e-04 | 71 | 99 | 4 | IPR000219 | |
| Domain | - | 5.50e-04 | 71 | 99 | 4 | 1.20.900.10 | |
| Domain | Plectin_repeat | 5.74e-04 | 7 | 99 | 2 | IPR001101 | |
| Domain | Plectin | 5.74e-04 | 7 | 99 | 2 | PF00681 | |
| Domain | PLEC | 5.74e-04 | 7 | 99 | 2 | SM00250 | |
| Domain | - | 1.12e-03 | 391 | 99 | 8 | 2.30.29.30 | |
| Domain | CRAL_TRIO_2 | 1.77e-03 | 12 | 99 | 2 | PF13716 | |
| Domain | PH_dom-like | 1.92e-03 | 426 | 99 | 8 | IPR011993 | |
| Domain | C1-set | 2.95e-03 | 54 | 99 | 3 | PF07654 | |
| Domain | IGc1 | 3.27e-03 | 56 | 99 | 3 | SM00407 | |
| Domain | Ig_C1-set | 3.61e-03 | 58 | 99 | 3 | IPR003597 | |
| Domain | Ig/MHC_CS | 3.61e-03 | 58 | 99 | 3 | IPR003006 | |
| Domain | IG_MHC | 3.97e-03 | 60 | 99 | 3 | PS00290 | |
| Domain | DH_1 | 4.56e-03 | 63 | 99 | 3 | PS00741 | |
| Domain | - | 4.97e-03 | 20 | 99 | 2 | 3.30.1330.20 | |
| Domain | - | 5.47e-03 | 21 | 99 | 2 | 1.10.287.600 | |
| Domain | Tubulin_C | 6.00e-03 | 22 | 99 | 2 | SM00865 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 1.19e-07 | 25 | 69 | 5 | MM15713 | |
| Pathway | REACTOME_ER_PHAGOSOME_PATHWAY | 1.53e-06 | 18 | 69 | 4 | MM14525 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 9.23e-06 | 9 | 69 | 3 | MM14527 | |
| Pathway | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | 1.14e-05 | 29 | 69 | 4 | M1062 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 2.39e-05 | 12 | 69 | 3 | M47529 | |
| Pathway | BIOCARTA_CTL_PATHWAY | 1.21e-04 | 20 | 69 | 3 | MM1374 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 2.39e-04 | 25 | 69 | 3 | MM1465 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 3.50e-04 | 6 | 69 | 2 | M47468 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.88e-04 | 7 | 69 | 2 | M47582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES | 4.88e-04 | 7 | 69 | 2 | M47530 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 5.17e-04 | 76 | 69 | 4 | MM14526 | |
| Pathway | WP_ALSTROM_SYNDROME | 6.02e-04 | 34 | 69 | 3 | M45524 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 8.31e-04 | 9 | 69 | 2 | M45020 | |
| Pubmed | Serial backcross analysis of genetic resistance to mousepox, using marker loci for Rmp-2 and Rmp-3. | 5.03e-09 | 8 | 103 | 4 | 1433507 | |
| Pubmed | Programme of self-reactive innate-like T cell-mediated cancer immunity. | 1.28e-07 | 16 | 103 | 4 | 35444279 | |
| Pubmed | 2.51e-07 | 5 | 103 | 3 | 22923333 | ||
| Pubmed | 3.39e-07 | 20 | 103 | 4 | 8747923 | ||
| Pubmed | SLC25A24 EPPK1 IPO8 HLA-C TRIO CAMSAP3 ARHGEF12 MPDZ PDIA3 PLEKHG6 COBL FGD5 PLEC DMD | 5.50e-07 | 916 | 103 | 14 | 32203420 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 1705528 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 2808323 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 21088134 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 69663 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 8.75e-07 | 7 | 103 | 3 | 12459592 | |
| Pubmed | Multiple sequences related to classical histocompatibility antigens in the mouse genome. | 8.75e-07 | 7 | 103 | 3 | 6264319 | |
| Pubmed | Sequence analysis of the C3H H-2K1k gene: relationship to the H-2 loci. | 8.75e-07 | 7 | 103 | 3 | 2714856 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 10500200 | ||
| Pubmed | Structural analysis of H-2Kf and H-2Kfm1 by using H-2K locus-specific sequences. | 8.75e-07 | 7 | 103 | 3 | 2391419 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 15671142 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 14215561 | ||
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 8.75e-07 | 7 | 103 | 3 | 28234229 | |
| Pubmed | Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse. | 8.75e-07 | 7 | 103 | 3 | 6242891 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 17512611 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 7018573 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 2642506 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 9037062 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 1840571 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 20957233 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 11580250 | ||
| Pubmed | V beta T cell repertoire of CD8+ splenocytes selected on nonpolymorphic MHC class I molecules. | 8.75e-07 | 7 | 103 | 3 | 11086076 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 12750360 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 18416856 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 8.75e-07 | 7 | 103 | 3 | 20974936 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 10704462 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 22573867 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 8.75e-07 | 7 | 103 | 3 | 2908875 | |
| Pubmed | Comparison of exon 5 sequences from 35 class I genes of the BALB/c mouse. | 8.75e-07 | 7 | 103 | 3 | 2584927 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 3496275 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 12147629 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 3458188 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 19462379 | ||
| Pubmed | Structural diversity of the classical H-2 genes: K, D, and L. | 8.75e-07 | 7 | 103 | 3 | 1730883 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 3680952 | ||
| Pubmed | Thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease. | 8.75e-07 | 7 | 103 | 3 | 19004778 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 8.75e-07 | 7 | 103 | 3 | 6300850 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 8.75e-07 | 7 | 103 | 3 | 6265910 | |
| Pubmed | Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. | 8.75e-07 | 7 | 103 | 3 | 18453559 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 8.75e-07 | 7 | 103 | 3 | 2906539 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 3013627 | ||
| Pubmed | DNA sequence of the mouse H-2Dd transplantation antigen gene. | 8.75e-07 | 7 | 103 | 3 | 3856254 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 3894562 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 27385590 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 8.75e-07 | 7 | 103 | 3 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 8.75e-07 | 7 | 103 | 3 | 18383043 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 16272298 | ||
| Pubmed | Tissue-specific expression of an unusual H-2 (class I)-related gene. | 8.75e-07 | 7 | 103 | 3 | 6956903 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 8833240 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 21178009 | ||
| Pubmed | Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. | 8.75e-07 | 7 | 103 | 3 | 6604582 | |
| Pubmed | Isolation of a cDNA clone for the murine transplantation antigen H-2Kb. | 8.75e-07 | 7 | 103 | 3 | 6954478 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 34525366 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 3374494 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 8.75e-07 | 7 | 103 | 3 | 3025084 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 2543831 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 8.75e-07 | 7 | 103 | 3 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 8.75e-07 | 7 | 103 | 3 | 6786753 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 6583704 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 6571712 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 9222352 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 12006653 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 1699529 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 17982076 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 7520098 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 15644207 | ||
| Pubmed | How a single T cell receptor recognizes both self and foreign MHC. | 8.75e-07 | 7 | 103 | 3 | 17418792 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 9185075 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 21483793 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 10452993 | ||
| Pubmed | Intestinal epithelial cells modulate CD4 T cell responses via the thymus leukemia antigen. | 8.75e-07 | 7 | 103 | 3 | 21900182 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 15272181 | ||
| Pubmed | Genetic control of scrapie and Creutzfeldt-Jakob disease in mice. | 8.75e-07 | 7 | 103 | 3 | 6408182 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 26714929 | ||
| Pubmed | Partial nucleotide sequence of H-2Dd major histocompatibility antigen gene. | 8.75e-07 | 7 | 103 | 3 | 3925012 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 6280871 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 10799615 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 10993729 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 1339405 | ||
| Pubmed | H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus. | 8.75e-07 | 7 | 103 | 3 | 10823851 | |
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 8.75e-07 | 7 | 103 | 3 | 19454713 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 10229092 | ||
| Pubmed | Comparison of nucleotide sequences of mRNAs belonging to the mouse H-2 multigene family. | 8.75e-07 | 7 | 103 | 3 | 6278432 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 7295646 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 2879284 | ||
| Pubmed | Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. | 8.75e-07 | 7 | 103 | 3 | 6952248 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 24064213 | ||
| Pubmed | Developmental Sculpting of Intracortical Circuits by MHC Class I H2-Db and H2-Kb. | 8.75e-07 | 7 | 103 | 3 | 25316337 | |
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 7306483 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 2903482 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 28475642 | ||
| Pubmed | 8.75e-07 | 7 | 103 | 3 | 2351932 | ||
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 8.57e-05 | 4 | 69 | 2 | 574 | |
| GeneFamily | Collagens|Collagen proteoglycans | 1.42e-04 | 5 | 69 | 2 | 575 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.98e-04 | 7 | 69 | 2 | 1299 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.96e-04 | 8 | 69 | 2 | 939 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 6.30e-04 | 44 | 69 | 3 | 588 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.14e-03 | 206 | 69 | 5 | 682 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.05e-03 | 66 | 69 | 3 | 722 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.49e-03 | 163 | 69 | 4 | 590 | |
| GeneFamily | Tubulins | 4.40e-03 | 26 | 69 | 2 | 778 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP | 2.57e-06 | 25 | 102 | 4 | MM672 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_EFFECTOR_T_CELL | 1.32e-05 | 132 | 102 | 6 | M39046 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 2.32e-05 | 87 | 102 | 5 | MM652 | |
| Coexpression | MIKKELSEN_MEF_ICP_WITH_H3K27ME3 | 2.73e-05 | 223 | 102 | 7 | MM838 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING | 3.09e-05 | 16 | 102 | 3 | MM3766 | |
| Coexpression | WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN | 5.30e-05 | 19 | 102 | 3 | MM797 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K27ME3 | 5.30e-05 | 19 | 102 | 3 | MM862 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 6.22e-05 | 20 | 102 | 3 | MM3682 | |
| Coexpression | RUAN_RESPONSE_TO_TNF_UP | 7.23e-05 | 21 | 102 | 3 | MM651 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.96e-05 | 114 | 103 | 6 | gudmap_kidney_P3_CapMes_Crym_k2_1000 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.52e-07 | 185 | 103 | 7 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-06 | 150 | 103 | 6 | fdbfc8f743cf848978cf0488493f6df60be53982 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.72e-06 | 169 | 103 | 6 | 17568e7aacfdcd96c469bae57d5ffad04954e9bd | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 176 | 103 | 6 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.04e-06 | 181 | 103 | 6 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.58e-06 | 185 | 103 | 6 | caf4f57f2db9ff72a652c8573e16e7ab180ffc05 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.50e-06 | 191 | 103 | 6 | f7a42a9d7493ea25cd8bd297c22e49e4bad7f0a4 | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 5.83e-06 | 193 | 103 | 6 | 3c8a022dbd4f8d25b14fd137ce64c2713a7dbe41 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.01e-06 | 194 | 103 | 6 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.01e-06 | 194 | 103 | 6 | ecdfc27d06e363fb23f0309f26ef6404a89f14ec | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.01e-06 | 194 | 103 | 6 | 866a9ca4c93c3c79c709a9d00def5392197f7e18 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.01e-06 | 194 | 103 | 6 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 198 | 103 | 6 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 198 | 103 | 6 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | (1)_T_cell-(10)_CD8_T|(1)_T_cell / shred on Cell_type and subtype | 6.95e-06 | 199 | 103 | 6 | d04896156e9ef6dda5f4f69fefdc7038c617d969 | |
| ToppCell | mLN-(1)_T_cell-(10)_CD8_T|mLN / shred on region, Cell_type, and subtype | 7.15e-06 | 200 | 103 | 6 | 6f02ba3a76e8aa3083efea9cb4ee587799c61fda | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.15e-06 | 200 | 103 | 6 | 04954fbe1e2264077228bb582c9a5897a70e6da2 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.15e-06 | 200 | 103 | 6 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-TYR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.15e-06 | 200 | 103 | 6 | bfdafb024a7b20d46837b2e6480dd4929253cd62 | |
| ToppCell | mLN-T_cell-CD8_T|mLN / Region, Cell class and subclass | 7.15e-06 | 200 | 103 | 6 | a221213f9245297a5d6196564c1043f8c17eb857 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-05 | 171 | 103 | 5 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | Int-URO-Lymphocyte-T_NK-dnT|Int-URO / Disease, Lineage and Cell Type | 4.98e-05 | 172 | 103 | 5 | e70299573da1679d6d286c3a43699cbff76e207d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.21e-05 | 88 | 103 | 4 | b4620e79ea80681305434707e87cb02a7c6a5e4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.21e-05 | 88 | 103 | 4 | 7992f8e621edf464bffcb70a6cc5f3b60c1d96f8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.21e-05 | 88 | 103 | 4 | b7b55f51af8ffa82813a4747580985a430da9ed1 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 176 | 103 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.71e-05 | 177 | 103 | 5 | 85e270b4a0b0da77ffe5987a099e827c02a4adf3 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 5.71e-05 | 177 | 103 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 181 | 103 | 5 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.34e-05 | 181 | 103 | 5 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.51e-05 | 182 | 103 | 5 | 3d7a8d2ee2137b098248597058974ef5ae09c19e | |
| ToppCell | RA-17._Lymphocyte|RA / Chamber and Cluster_Paper | 6.51e-05 | 182 | 103 | 5 | 257a7847917b6ea1d60608183d90300bfd028758 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.51e-05 | 182 | 103 | 5 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | RA-17._Lymphocyte|World / Chamber and Cluster_Paper | 6.68e-05 | 183 | 103 | 5 | 6397f684a50346fc42cccb5afbe10350f4b2d9b0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.04e-05 | 185 | 103 | 5 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.04e-05 | 185 | 103 | 5 | 8314dc608bc837df3037e89afd9db39737374ebc | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.40e-05 | 187 | 103 | 5 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.78e-05 | 189 | 103 | 5 | f1129eb122bbc051457c5545f1a267beb988b0f2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.78e-05 | 189 | 103 | 5 | 0b012ee301419fa9ccc387c3ff66c2344b349a97 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 7.98e-05 | 190 | 103 | 5 | 10bece40d980d37a01dae8ce887655bf9f93040c | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_CD8+_T|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.98e-05 | 190 | 103 | 5 | cb4cf8ae2156c20b7978ae2e55aa605b4e90f455 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.98e-05 | 190 | 103 | 5 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.98e-05 | 190 | 103 | 5 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|lymph-node_spleen / Manually curated celltypes from each tissue | 8.18e-05 | 191 | 103 | 5 | f802a4686ecf00e8302047bfe23356f24b266cf8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 8.38e-05 | 192 | 103 | 5 | 4d72b9264ed62e0c08cde4078061b348253f6989 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.38e-05 | 192 | 103 | 5 | 1922b0350d3375e67c314dbce8074e5cf986f2ef | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.38e-05 | 192 | 103 | 5 | 97c197643e59835c6d45dde9e549c9a1b1bb7288 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.38e-05 | 192 | 103 | 5 | 7a122505d7adf236e0cbd9bcbc98e7c537600ca3 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.38e-05 | 192 | 103 | 5 | a4d161e3d48bc020e687808b352325ef9d1cc1f3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.38e-05 | 192 | 103 | 5 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.59e-05 | 193 | 103 | 5 | 5c6b03d6d98aa873fda1a201d44a912246bb5a92 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.59e-05 | 193 | 103 | 5 | d66cbb8c71bdc57faecb74a16fe3f34cb0b33228 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.59e-05 | 193 | 103 | 5 | c1d9c2436503791350086a503d6b98c5c69f44ae | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.59e-05 | 193 | 103 | 5 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.59e-05 | 193 | 103 | 5 | d4b58eee97043b4337ec36c40f9af6499d864df9 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.59e-05 | 193 | 103 | 5 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-05 | 193 | 103 | 5 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | e1b7ef4ba2ab14d3c839b6305d91efcfd0826220 | |
| ToppCell | (1)_T_CD8_CTL|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.01e-05 | 195 | 103 | 5 | f582b854e5a4c52764aad5abe4e28ea77a7445f7 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.01e-05 | 195 | 103 | 5 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 9.01e-05 | 195 | 103 | 5 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.01e-05 | 195 | 103 | 5 | 4a60b51f92830882872f2fe1a911db2970faf071 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 9.01e-05 | 195 | 103 | 5 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | 15-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 9.01e-05 | 195 | 103 | 5 | 9e9283a397f56732a0a5f2e2527f154d4c2dd56a | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMH+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.01e-05 | 195 | 103 | 5 | 1a7c2c4cf30df435770794a989be438579bf98f2 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | ac601d53e20ca2edd022764cf2c239461ec119c7 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_CTL|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.23e-05 | 196 | 103 | 5 | ad9b0651cb2a15b750e453b2dcf782bca08b4fe7 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 9.23e-05 | 196 | 103 | 5 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-05 | 196 | 103 | 5 | 3dc6394c5de1f875a19ad0e8799827fad29f8f02 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.23e-05 | 196 | 103 | 5 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.23e-05 | 196 | 103 | 5 | 5b5cf6f70534661d694f47359b6595b4580876c3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.23e-05 | 196 | 103 | 5 | 8e1ed30256a031bb90dac1f167e074c68efbed74 | |
| ToppCell | 11.5-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 9.23e-05 | 196 | 103 | 5 | 2648d64b0e7b59ae78182d55f32699ceea37ff8d | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | 2d55f5a683e574873aee908da0b02b450d9340df | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-05 | 196 | 103 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.23e-05 | 196 | 103 | 5 | 756e76440a92fa35ec8f6ad4900110ab202810cf | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 9.23e-05 | 196 | 103 | 5 | 1868ad537b7f04cdad0a0c8282aadbc4f257a722 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.46e-05 | 197 | 103 | 5 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lung / Location, Cell class and cell subclass | 9.46e-05 | 197 | 103 | 5 | de26ca046038e34790cece24529a05d491e6f8ef | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.46e-05 | 197 | 103 | 5 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD8-Tem/emra_CD8|Liver / Manually curated celltypes from each tissue | 9.69e-05 | 198 | 103 | 5 | 2fc2a4638c458ae793ac090a29d27b75fc9e6af6 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial-Astroglia|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.69e-05 | 198 | 103 | 5 | 715ecad21f572b195ff3b78216b1a7b32bbb4ace | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 198 | 103 | 5 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Macroglial|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.69e-05 | 198 | 103 | 5 | 9d03768f8b6c74e060c5f045508538f9b331f469 | |
| ToppCell | T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 9.69e-05 | 198 | 103 | 5 | 1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD8-positive,_alpha-beta_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.69e-05 | 198 | 103 | 5 | 41ead3d3733b79e3e45648d5ce1909e617c35ed7 | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.69e-05 | 198 | 103 | 5 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.92e-05 | 199 | 103 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | PBMC-Severe|PBMC / Compartment, Disease Groups and Clusters | 9.92e-05 | 199 | 103 | 5 | b428d95d3c90b28f658f652a768588a8ced4abd9 | |
| ToppCell | COVID-19_Mild-CD8+_Tem|COVID-19_Mild / Disease condition and Cell class | 9.92e-05 | 199 | 103 | 5 | 9016fbe5fe55e1ffa279ee8e8db3c93b5cf914d5 | |
| ToppCell | Caecum-T_cell-CD8_T|Caecum / Region, Cell class and subclass | 1.02e-04 | 200 | 103 | 5 | 8c0ced6cbfde40c2a9b54953c6fe93d83ad001d7 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 103 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 103 | 5 | 1db27223e307efca97502fca40ec5e4f8eea512b | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 103 | 5 | 72e1cc0b222df3ab76164524676e91628e237995 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | severe-CD8+_Tem|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-04 | 200 | 103 | 5 | aaa2cd326dc15dee2fd975ca133359c5826f6a75 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 1.02e-04 | 200 | 103 | 5 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 103 | 5 | 6b34f2b85d4f83c1270ee151f602cba6f42042ba | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 103 | 5 | 1d67c5d2c617749b521e70879950dea2c9d076d6 | |
| ToppCell | Caecum-(1)_T_cell-(10)_CD8_T|Caecum / shred on region, Cell_type, and subtype | 1.02e-04 | 200 | 103 | 5 | 4276d8e21a1bb3cf51f238455bb072a7600f9253 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 8.12e-06 | 307 | 97 | 8 | EFO_0004612, EFO_0020946 | |
| Disease | complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology) | 1.07e-05 | 2 | 97 | 2 | DOID:0090138 (implicated_via_orthology) | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 2.22e-04 | 7 | 97 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | group XIIB secretory phospholipase A2-like protein measurement | 2.22e-04 | 7 | 97 | 2 | EFO_0801657 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.96e-04 | 274 | 97 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 3.92e-04 | 104 | 97 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 5.04e-04 | 303 | 97 | 6 | EFO_0004612, EFO_0020945 | |
| Disease | beta-2 microglobulin measurement | 5.77e-04 | 11 | 97 | 2 | EFO_0005197 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 6.18e-04 | 315 | 97 | 6 | EFO_0004574, EFO_0004612 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 6.82e-04 | 321 | 97 | 6 | EFO_0004612, EFO_0004639 | |
| Disease | granulins measurement | 6.91e-04 | 12 | 97 | 2 | EFO_0008141 | |
| Disease | lymphocyte count | ILRUN EPPK1 HLA-A SYT12 HLA-C IQGAP2 TUBG1 TENM4 ALMS1 DNAH17 CD300LG PLEC ZC3H7B | 1.01e-03 | 1464 | 97 | 13 | EFO_0004587 |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.10e-03 | 137 | 97 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.18e-03 | 239 | 97 | 5 | EFO_0010934 | |
| Disease | bipolar I disorder | 1.23e-03 | 141 | 97 | 4 | EFO_0009963 | |
| Disease | serum IgE measurement | 1.24e-03 | 64 | 97 | 3 | EFO_0004579 | |
| Disease | phospholipids in very large HDL measurement | 1.36e-03 | 66 | 97 | 3 | EFO_0022298 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.66e-03 | 153 | 97 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | osteoarthritis, knee | 1.86e-03 | 158 | 97 | 4 | EFO_0004616 | |
| Disease | serum alanine aminotransferase measurement | 2.27e-03 | 869 | 97 | 9 | EFO_0004735 | |
| Disease | obsolete aging | 2.32e-03 | 279 | 97 | 5 | GO_0007568 | |
| Disease | nucleus accumbens volume | 2.37e-03 | 22 | 97 | 2 | EFO_0006931 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.78e-03 | 291 | 97 | 5 | EFO_0008317, EFO_0020946 | |
| Disease | lipoprotein measurement, phospholipid measurement | 2.80e-03 | 85 | 97 | 3 | EFO_0004639, EFO_0004732 | |
| Disease | serum gamma-glutamyl transferase measurement | 3.17e-03 | 914 | 97 | 9 | EFO_0004532 | |
| Disease | age at menopause | 3.25e-03 | 302 | 97 | 5 | EFO_0004704 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPETEADGFVLLGDT | 16 | C9J7I0 | |
| GEVFADESSVPSLEL | 251 | Q8N944 | |
| FGETNIPESLVTGED | 46 | B9A014 | |
| EGSFTSLTGLLEVEP | 1551 | Q9NR09 | |
| DTEVTDFPSLEEGIL | 181 | Q8TCU4 | |
| PGGAEEISEVLDSLE | 1296 | P11532 | |
| ATTGVDLDVTLPGEG | 101 | Q9H9G7 | |
| EDLFGLVPFDEITGS | 951 | Q9NSY1 | |
| LEEEASSEGEPRVGL | 871 | Q9P1Y5 | |
| DLEFKTEFIGGSTPE | 786 | Q96BY7 | |
| EEEGPVINFDGATTL | 316 | P59510 | |
| EEGSETQVPGLDISA | 301 | Q16790 | |
| LTVSEAETDPGDVLG | 276 | Q9NZN5 | |
| STEEEGFTLDPIDIS | 271 | Q9H4I0 | |
| GTDITFPDGDQELDL | 346 | Q86U06 | |
| DTELVETRPAGDGTF | 251 | P01893 | |
| SDVTLTPEVEEFLGA | 1416 | Q6ZRR7 | |
| SEDGELSIENPFGET | 501 | Q9Y2U8 | |
| FLLETSEEGSGPLIS | 951 | Q8N612 | |
| EPGENGTSLTDEELV | 16 | O15525 | |
| LVTEETPSGEAGSEE | 151 | Q9UMS0 | |
| ETGVELLGSPVEDTS | 31 | Q86WG3 | |
| ELELDSGVEGEAPSS | 16 | Q6DN90 | |
| GEVSEEEELTPFSLD | 141 | Q8N3T1 | |
| GRPSGEAFVELESEE | 51 | P55795 | |
| DTELVETRPAGDGTF | 251 | P10321 | |
| FEILGPSGSQLTDDV | 81 | Q16659 | |
| GLSEPEEDIGDTAVR | 176 | P53370 | |
| TFEEDAPGTVIGTLA | 36 | O95206 | |
| GFTIAPEKEEGSSEV | 1411 | Q6ZNL6 | |
| DETSLEGGISPDLVL | 326 | Q6NV75 | |
| EKEVEGSGFPETRTL | 586 | Q8N3D4 | |
| TPFDLAEGESELVSG | 196 | P03886 | |
| GLISSVEEIPEDAAS | 886 | Q92887 | |
| VEAEEELTPSSGDGL | 171 | Q07075 | |
| DIELLEDSGIPTEAF | 321 | Q96JA3 | |
| IVDETLDFGGLSPSD | 11 | Q6PGN9 | |
| FIEGSLLTPKGEDSE | 431 | Q969R2 | |
| SGEVLETTAPGVEDI | 1016 | P16112 | |
| GEVLETTAPGVEDIS | 1036 | P16112 | |
| EVLETTAPGVEDISG | 1056 | P16112 | |
| EDISGLPSGEVLETT | 1066 | P16112 | |
| EDISGLPSGEVLETA | 1161 | P16112 | |
| EDISGLPSGEVLETA | 1256 | P16112 | |
| EDISGLPSGEVLETA | 1351 | P16112 | |
| GEVLETTAPGVDEIS | 1416 | P16112 | |
| EEISGLPSGEVLETS | 1446 | P16112 | |
| SGIEDVSELPSGEGL | 1501 | P16112 | |
| PTTFKEEEGLGSVEL | 1841 | P16112 | |
| EEEGLGSVELSGLPS | 1846 | P16112 | |
| SSGEEEEEGPLFLKA | 711 | Q3KR16 | |
| DELDETDTPGSEVGL | 571 | Q8NC74 | |
| EITEPVSGSDEAKLG | 266 | A6NGY1 | |
| SFVEDVTIGEGESIP | 76 | Q9H6K1 | |
| DGFTSEGEILEISDI | 171 | A6NGN9 | |
| PGEDVALLSVSFEDT | 196 | Q9NXR7 | |
| EDGFSIPLAGEETTE | 706 | Q99715 | |
| DEDGLTFNPTLEVGS | 906 | Q9UFH2 | |
| ESTGGFSEEAEIPGI | 331 | P01031 | |
| VTFIGEVSDDPVDSG | 541 | O75128 | |
| LQEEDLGTAEFGVTP | 76 | P56202 | |
| TEEEPDGTLGSLEVE | 121 | Q7Z591 | |
| ESGEIDLDGLDTPSE | 76 | Q12982 | |
| DTELVETRPAGDGTF | 251 | P04439 | |
| VPEDFILGIEDDTSS | 211 | Q96EH3 | |
| TFDPGTVEDGLLTVE | 281 | O60381 | |
| SLEGSALAGTPEEEE | 381 | Q9Y6H8 | |
| AESGTILEPLFTESE | 1306 | Q9C0D2 | |
| AATTEEPLITAGGEE | 511 | P39059 | |
| DLGGSTLEDPTDLEI | 126 | P55291 | |
| QGSPELFSIDELTGE | 196 | P55291 | |
| GLTEDQFIRTPTGDE | 631 | P28340 | |
| VEESGESELSVISGP | 406 | Q8N309 | |
| EELVTRETGDGDPVS | 1356 | Q5THK1 | |
| VLEETALEGFSTPLD | 936 | O15397 | |
| GFESKPGTEEEEITV | 861 | Q5JY77 | |
| TSFSDIELLEDSGIP | 201 | O95397 | |
| EDTFESISELGPLEL | 101 | Q8IV01 | |
| GTITFLPLEEDDEGN | 211 | Q8IYL2 | |
| ALETSSPIEEDFEGI | 1101 | Q8IWB6 | |
| NEEDPTVLELGITGS | 91 | P27169 | |
| DSDGGSEEVVLTPAE | 11 | Q9BRT9 | |
| VEISSLPDGTTFEDI | 336 | P48380 | |
| EVPTVESFLGEGAVD | 1246 | Q13576 | |
| LSDFGLESTAGEIPV | 311 | P30101 | |
| GDLETPSSGDEGEIL | 366 | O14594 | |
| EELLAEFGSGTLDLP | 2551 | P58107 | |
| GPEEISGFEGDTVSL | 21 | Q6UXG3 | |
| PTDGSEIVLLTDGED | 401 | A8K7I4 | |
| AGSDPSLEFLVVSEE | 276 | Q13057 | |
| ETIGPLSEGDSDEEI | 36 | Q9HAW4 | |
| TVEFDDGDTGRIPLS | 2261 | O15417 | |
| TEDSLDEGPGALVLE | 21 | Q8N8E2 | |
| GPELDSGASVEEALE | 556 | Q92738 | |
| EEISETGELVGPFVS | 26 | Q9BTP6 | |
| LGEFIGSSETEDPVL | 661 | O75970 | |
| SSELEFGGTLEDEEP | 681 | Q9BZQ8 | |
| ISPEGIVEEFATEGT | 31 | P23258 | |
| EGLGFNLTETPEADI | 101 | Q86U17 | |
| LEEEVAPGSPFSITE | 666 | Q5T4T6 | |
| SEGSTDVDEPLEVFI | 331 | P23497 | |
| ELLDLTRTFPSGGEE | 396 | Q9C0C2 | |
| PTAIEGAEDGLDSTV | 56 | Q9BSE2 | |
| PEDSFIDSGEIDVGR | 426 | Q6N022 | |
| ALSGAELPGTVESVE | 1221 | Q9H254 | |
| TEETGPVAGILDTET | 4411 | Q15149 | |
| FVLTEPELTGELGDD | 46 | Q6ZVL8 | |
| ISPEGIVEEFATEGT | 31 | Q9NRH3 | |
| FTEGEDKITLEGPTE | 401 | Q00341 | |
| EEKEESEFLPSSGGT | 546 | O94979 | |
| DGDLEGPVIDESVLS | 196 | Q5VYS8 | |
| GLLEDESGTEAAPIE | 1116 | Q6ZQQ6 | |
| GIDIGDSLTIPDEFT | 171 | Q6NUK1 | |
| LSGVSPFLDDSVEET | 2986 | O75962 | |
| AFGEGELTPIAVDTT | 521 | Q9P1Q0 | |
| SDGDVFGPELDTLLD | 256 | Q9UGR2 | |
| KEIFTGEEGPESSEF | 51 | Q9UJN7 |